563 related articles for article (PubMed ID: 27197156)
21. Base-resolution stratification of cancer mutations using functional variomics.
Yi S; Liu NN; Hu L; Wang H; Sahni N
Nat Protoc; 2017 Nov; 12(11):2323-2341. PubMed ID: 28981122
[TBL] [Abstract][Full Text] [Related]
22. Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
[TBL] [Abstract][Full Text] [Related]
23. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
Chang YS; Huang HD; Yeh KT; Chang JG
Int J Oncol; 2017 May; 50(5):1778-1784. PubMed ID: 28339086
[TBL] [Abstract][Full Text] [Related]
25. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
26. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
[TBL] [Abstract][Full Text] [Related]
27. Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets.
Anoosha P; Sakthivel R; Michael Gromiha M
Biochim Biophys Acta; 2016 Feb; 1862(2):155-65. PubMed ID: 26581171
[TBL] [Abstract][Full Text] [Related]
28. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
29. OncoBase: a platform for decoding regulatory somatic mutations in human cancers.
Li X; Shi L; Wang Y; Zhong J; Zhao X; Teng H; Shi X; Yang H; Ruan S; Li M; Sun ZS; Zhan Q; Mao F
Nucleic Acids Res; 2019 Jan; 47(D1):D1044-D1055. PubMed ID: 30445567
[TBL] [Abstract][Full Text] [Related]
30. DriverDBv2: a database for human cancer driver gene research.
Chung IF; Chen CY; Su SC; Li CY; Wu KJ; Wang HW; Cheng WC
Nucleic Acids Res; 2016 Jan; 44(D1):D975-9. PubMed ID: 26635391
[TBL] [Abstract][Full Text] [Related]
31. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
[TBL] [Abstract][Full Text] [Related]
32. Tumor Mutation Burden Computation in Two Pan-Cancer Precision Medicine Next-Generation Sequencing Panels.
Shu Y; Wu X; Shen J; Luo D; Li X; Wang H; Tang YT
J Comput Biol; 2020 Oct; 27(10):1553-1560. PubMed ID: 32311294
[TBL] [Abstract][Full Text] [Related]
33. Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
Liu Y; Yasukawa M; Chen K; Hu L; Broaddus RR; Ding L; Mardis ER; Spellman P; Levine DA; Mills GB; Shmulevich I; Sood AK; Zhang W
JAMA Oncol; 2015 Jul; 1(4):486-94. PubMed ID: 26181259
[TBL] [Abstract][Full Text] [Related]
34. Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.
Shimoda Y; Nagashima T; Urakami K; Tanabe T; Saito J; Naruoka A; Serizawa M; Mochizuki T; Ohshima K; Ohnami S; Ohnami S; Kusuhara M; Yamaguchi K
Biomed Res; 2016; 37(6):367-379. PubMed ID: 28003584
[TBL] [Abstract][Full Text] [Related]
35. Ontology-based prediction of cancer driver genes.
Althubaiti S; Karwath A; Dallol A; Noor A; Alkhayyat SS; Alwassia R; Mineta K; Gojobori T; Beggs AD; Schofield PN; Gkoutos GV; Hoehndorf R
Sci Rep; 2019 Nov; 9(1):17405. PubMed ID: 31757986
[TBL] [Abstract][Full Text] [Related]
36. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
37. Identification of Local Clusters of Mutation Hotspots in Cancer-Related Genes and Their Biological Relevance.
Rhee JK; Yoo J; Kim KR; Kim J; Lee YJ; Chul Cho B; Kim TM
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(5):1656-1662. PubMed ID: 29993813
[TBL] [Abstract][Full Text] [Related]
38. Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
Kim D; Li R; Dudek SM; Wallace JR; Ritchie MD
Pac Symp Biocomput; 2015; ():96-107. PubMed ID: 25592572
[TBL] [Abstract][Full Text] [Related]
39. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.
Peveling-Oberhag J; Wolters F; Döring C; Walter D; Sellmann L; Scholtysik R; Lucioni M; Schubach M; Paulli M; Biskup S; Zeuzem S; Küppers R; Hansmann ML
BMC Cancer; 2015 Oct; 15():773. PubMed ID: 26498442
[TBL] [Abstract][Full Text] [Related]
40. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]